Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD

NCT02182856 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Ipratropium bromide 500 µg/salbutamol sulphate 3 mg
DRUG: Ipratropium 500 µg
DRUG: Salbutamol sulphate 3 mg
DRUG: Salbutamol sulphate 6 mg

Sponsor

Boehringer Ingelheim